Hitinder S. Gurm, M.D.
Dr. Hitinder S. Gurm is the Associate Chief of the Division of Cardiovascular Medicine at the University of Michigan. He is also the Chief of the Section of Cardiology at the VA Ann Arbor Healthcare System. He leads the Blue Cross Blue Shield Cardiovascular Consortium (BMC2) and is the project director of BMC2-PCI, a multi-center, quality improvement registry funded by Blue Cross Blue Shield of Michigan, designed to improve quality of care and outcomes for patients who undergo percutaneous coronary interventions in the state of Michigan. Hitinder is a graduate of Christian Medical College, Ludhiana, India. He did his residency in Internal medicine followed by fellowship in Cardiology and Interventional Cardiology at the Cleveland Clinic Foundation. His research interests include carotid interventions, contrast induced nephropathy, quality improvement and outcomes assessment, and development of novel devices for endovascular interventions. He has published more than 200 original articles and book chapters, and has been named as an inventor on 4 patents. He is the recipient of the Michigan Health & Hospital Association’s Patient Safety & Quality Leadership Award for 2016 and has been elected to the American Society for Clinical investigation (ASCI).
Peter Henke, M.D.
Dr. Henke is a Leland Ira Doan Professor of Surgery, operating both at the University of Michigan and the Veteran's Administration Hospital. He graduated from the University of Wisconsin with a Bachelor of Science in Biochemistry and Molecular Biology in 1988 and from the University Of Wisconsin School Of Medicine in 1992. He did his General Surgery residency at the University of Louisville. He joined the University of Michigan for his Vascular Surgery fellowship, and graduated to join the faculty in 2000. His clinical and research focus is on lower extremity arterial, venous, and vascular medicine patient issues. He also acts as the Associate Chair for Research in the Department of Surgery. Dr. Henke is the Project Director of the Blue Cross Blue Shield of Michigan Cardiovascular Consortium - Vascular Surgery initiative (BMC2). This is a multi-center, multi-disciplinary outcomes registry that represents a regional collaborative effort to assess and improve the quality of care and the outcomes of patients with cerebrovascular or peripheral vascular disease who undergo open bypass revascularization, abdominal aneurysm repair, carotid endarterectomy, or carotid stenting.
Andrea G. Jensen, M.A., M.S.
Ms. Andrea G. Jensen is the Research Senior Supervisor for the BMC2 Collaborative. BMC2-PCI is a multi-center, quality improvement registry supported by Blue Cross Blue Shield of Michigan, designed to improve quality of care and outcomes for patients who undergo percutaneous coronary interventions. The BMC2 Vascular Surgery Initiative is a multi-center, multi-disciplinary outcomes registry that represents a regional collaborative effort to assess and improve the quality of care and the outcomes of patients with cerebrovascular or peripheral vascular disease who undergo open bypass revascularization, abdominal aneurysm repair, carotid endarterectomy, or carotid stenting. She was previously the Site Head for Research Quality Assurance at the Ann Arbor Site for Pfizer Global Research and Development. Ms. Jensen has many years of management experience in health care and in public health. She has an MA in Analytic Philosophy and an MS in Preventive Medicine and Environmental Health from the University of Iowa.
Other Office Personnel:
Sheryl Fielding, Erin Jeruzal, Kathleen Frazier, Pam Benci, Ryan Hughes, Nate Yost, John Sly, & Milan Seth
- About BMC2
- BMC2 Collaborative
- Upcoming Meetings